The overall chance of surviving without long-term respiratory or neurodevelopmental disability was 4/56 ( 7.1 % ) ; 4/28 ( 14.3 % ) in the amnioinfusion group and 0/28 in the expectant group ( RR 9.0 ( 95 % CI , 0.51-159 .70 ) ) .